POLISCOPE
Back to feed

The civic record

Read. Follow. Verify.

National Hepatitis Testing Day, 2024

Record date · May 17, 2024

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

President Biden issued a proclamation designating May 19, 2024, as National Hepatitis Testing Day to raise awareness about viral hepatitis. The document highlights the administration's proposed plans to increase testing, expand access to treatments, and improve vaccination rates for hepatitis B and C.

Why it matters

This proclamation highlights federal health priorities and proposed policy changes regarding the diagnosis and treatment of viral hepatitis in the United States.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Uninsured individuals

The proposed subscription model for hepatitis C drugs aims to expand access to medication for this group.

Directly affected

Medicaid enrollees

The proposed subscription model for hepatitis C drugs includes individuals enrolled in Medicaid.

Directly affected

Healthcare professionals

The administration's plan includes investments in training programs for healthcare professionals.

Key Facts

  • May 19, 2024, is designated as National Hepatitis Testing Day.
  • Hepatitis C is curable with treatment that is 95 percent effective.
  • The administration proposes a subscription model to expand access to hepatitis C drugs for uninsured and specific public program enrollees.
  • The CDC recommends hepatitis B vaccination for children and screening/vaccination for adults under 60.

Frequently Asked Questions

What is the purpose of National Hepatitis Testing Day?
It is intended to raise awareness about viral hepatitis and encourage Americans to get tested and vaccinated.
What specific actions is the administration proposing regarding hepatitis?
The administration has proposed a plan to accelerate , launch a for hepatitis C drugs, and increase funding for medical training and research.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Subscription Drug Model

The administration is proposing a shift toward a subscription-based payment model for hepatitis C medications to increase accessibility.

Connected Entities

Centers for Disease Control and Prevention, Joseph R. Biden Jr., 3395

Sources

Open source document

www.federalregister.gov

Analysis Score

0–100
  • Significance45
    How much this matters to a regular citizen
  • Controversy10
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record